Safety Study of Apixaban in Recent Acute Coronary Syndrome

NCT00313300 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1741

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Coronary Syndrome (ACS)

Interventions

DRUG: Apixaban
DRUG: Apixaban
DRUG: Placebo
DRUG: Apixaban

Sponsor

Bristol-Myers Squibb